We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$29.6B
AUM Growth
+$2.09B
Cap. Flow
+$1.9B
Cap. Flow %
6.41%
Top 10 Hldgs %
35.06%
Holding
589
New
76
Increased
233
Reduced
176
Closed
64

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$171M
2
AMZN icon
Amazon
AMZN
+$106M
3
TSM icon
TSMC
TSM
+$90.2M
4
PXD
Pioneer Natural Resource Co.
PXD
+$72.5M
5
GE icon
GE Aerospace
GE
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 29.91%
2 Healthcare 22.8%
3 Financials 10.47%
4 Communication Services 9.58%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLF icon
151
Cleveland-Cliffs
CLF
$6.49B
$26.3M 0.09%
1,709,838
+133,291
+8% +$2.39M
BIO icon
152
Bio-Rad Laboratories Class A
BIO
$8.76B
$26.3M 0.09%
96,133
+2,781
+3% +$809K
CTLT
153
DELISTED
CATALENT, INC.
CTLT
$26.2M 0.09%
+466,751
New +$26M
FOX icon
154
Fox Class B
FOX
$22.1B
$25.8M 0.09%
804,562
+9,466
+1% +$286K
WBA
155
DELISTED
Walgreens Boots Alliance
WBA
$25.4M 0.09%
2,103,111
+298,993
+17% +$5.07M
PARA
156
DELISTED
Paramount Global Class B
PARA
$25.4M 0.09%
2,441,709
-134,002
-5% -$1.57M
BLD
157
DELISTED
TopBuild
BLD
$25.1M 0.08%
65,034
+4,007
+7% +$1.63M
FN icon
158
Fabrinet
FN
$14.9B
$25M 0.08%
102,255
-41,419
-29% -$8.79M
SOLV icon
159
Solventum
SOLV
$15.3B
$24.9M 0.08%
+471,473
New +$28.6M
VMI icon
160
Valmont Industries
VMI
$8.86B
$24.8M 0.08%
90,400
+52,500
+139% +$12.8M
BNS icon
161
Scotiabank
BNS
$105B
$24.7M 0.08%
539,193
+127,150
+31% +$6.02M
MRO
162
DELISTED
Marathon Oil Corporation
MRO
$24.5M 0.08%
853,186
+447,878
+111% +$12.4M
CW icon
163
Curtiss-Wright
CW
$25.1B
$24.4M 0.08%
90,198
-10,991
-11% -$2.94M
NXT icon
164
Nextpower Inc
NXT
$14.1B
$24.4M 0.08%
+520,900
New +$25.9M
ARCB icon
165
ArcBest
ARCB
$3.15B
$24M 0.08%
224,080
+52,844
+31% +$6.37M
ORA icon
166
Ormat Technologies
ORA
$5.8B
$23.8M 0.08%
+332,607
New +$23.1M
NTR icon
167
Nutrien
NTR
$33.9B
$23.4M 0.08%
460,181
+122,042
+36% +$6.68M
ARMK icon
168
Aramark
ARMK
$15B
$23.2M 0.08%
682,924
+275,540
+68% +$8.94M
ETSY icon
169
Etsy
ETSY
$8.12B
$22.7M 0.08%
385,607
+20,205
+6% +$1.29M
PCH
170
DELISTED
PotlatchDeltic
PCH
$22.7M 0.08%
577,327
-303,567
-34% -$12.9M
MBUU icon
171
Malibu Boats
MBUU
$548M
$22.7M 0.08%
648,920
+131,967
+26% +$4.83M
CARR icon
172
Carrier Global
CARR
$49.8B
$22.6M 0.08%
357,500
+89,000
+33% +$5.46M
ACGL icon
173
Arch Capital
ACGL
$36.5B
$22.3M 0.08%
220,876
+178,629
+423% +$17.4M
EAF icon
174
GrafTech
EAF
$184M
$22.1M 0.07%
2,277,293
CBRE icon
175
CBRE Group
CBRE
$43.3B
$22M 0.07%
247,003
+174,536
+241% +$15.5M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2024 Portfolio in Review

As of Q2 2024, Grantham, Mayo, Van Otterloo & Co (GMO) held 589 positions worth $29.6B, up 7.6% from $27.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.9B of net new capital in Q2 2024, opening 76 new positions and adding to 233 existing holdings. Its largest new stake was Thermo Fisher Scientific: 425,639 shares worth $235M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $171M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2024 buy was Thermo Fisher Scientific: 425,639 shares worth $235M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Apple in Q2 2024, an estimated $275M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $171M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $72.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 35% of its $29.6B portfolio in Q2 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 64 in Q2 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 7.6% quarter-over-quarter to $29.6B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2024, filed 13 Aug 2024.